![System.Func`1[System.String]](/siteassets/images/z-mckesson-logosicons/health-systems2.png)
Explore the value a strategic partnership can bring in helping take your health system pharmacy further to achieve more.
MHS In the News: Transparency in Drug Pricing Can Start with 340B
Key considerations in understanding 340B program results and benefits.
By
Date
July 13, 2021
Read time: less than 1 minute
A lack of transparency across the pharmacy marketplace stems from a number of different factors. Ultimately, it impacts the patient experience and can create confusion.
Heightened transparency across the broader system could help support health systems’ ability to generate savings and revenue to support extending care to the uninsured and underinsured, which is key to extending pharmacy and patient care services.
Andrew Wilson, vice president, 340B Solutions for McKesson, shares three key considerations in understanding 340B program results and benefits. Read more from Drug Topics.
Related Stories
Use this comprehensive library of resources to find important information on what’s changing with 340B and IRA, when, and why it may matter for your health system pharmacy.
Hear part two of LogiPharma’s interview with McKesson Health Systems President Ammie McAsey.
McKesson Health Systems President Ammie McAsey joins a keynote panel to discuss the growing importance of collaboration across the healthcare ecosystem.
McKesson Health Systems President Ammie McAsey contributes expert insights on how we’re enabling pharmacy to do more for the advancement of patient health.
An interactive experience highlighting key insights for success across 8 domains of specialty pharmacy.
Does your health system have a dedicated concierge service monitoring contract pricing accuracy now and in the future?
This American Pharmacists Month, we honor the people, patients, and partnerships that define the extraordinary impact of health system pharmacy in the community and beyond.
The most downloaded content by health system pharmacy leaders in September 2025.
One of our Specialty Pharmacy Enablement (SPE) experts outlines her three-pronged approach for success and suggests the addition of a critical fourth.